4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001209191-20-049618
SVP, Finance and CFO sold 15,004 shares at $50.91 ($763,854)
- SVP, Finance and CFO acquired 15,004 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cotroneo Pat · SVP, Finance and CFO
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-03 | Exercise or conversion : show line 1 in the form | +637 | $29.66 | $18,893 | 278,947 | D |
| 2020-09-03 | Exercise or conversion : show line 2 in the form | +5,696 | $19.39 | $110,445 | 284,643 | D |
| 2020-09-03 | Exercise or conversion : show line 3 in the form | +8,671 | $25.40 | $220,243 | 293,314 | D |
| 2020-09-03 | Sale : show line 4 in the form | −15,004 | $50.91 | $763,854 | 278,310 | D |
| Open-market sales · 15,004 sh · avg $50.91 · $763,854 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-09-03 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −637 | $29.66 | 2025-03-04 | 637 | 4,618 | D |
| 2020-09-03 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −5,696 | $19.39 | 2026-02-22 | 5,696 | 0 | D |
| 2020-09-03 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −8,671 | $25.40 | 2027-03-08 | 8,671 | 41,579 | D |
Loading xslF345X03/doc4.xml…